| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/30/2002 | WO2002042279A1 Imidazolone derivatives for the treatment of viral diseases |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042254A1 PROCESS OF PRODUCING CARBONYL a-SUBSTITUTED NITROGEN-CONTAINING COMPOUNDS |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2002041886A1 Ydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections |
| 05/30/2002 | WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | US20020065391 Compound for use in the treatment of arthritis, inflammatory bowel disease, nervous system and cardiovascular disorders, arteriosclerosis, restenoses, diabetes, grafted organ damage, asthma, allergies, tumor metastasis and malaria |
| 05/30/2002 | US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc. |
| 05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
| 05/30/2002 | US20020065274 Methods of using novel compounds as neuro-protective agents |
| 05/30/2002 | US20020065271 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2428461A1 Imidazolone derivatives for the treatment of viral diseases |
| 05/29/2002 | EP1208109A2 Nucleoside analogues |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP1208088A2 Fluorene derivatives as integrin inhibitors |
| 05/29/2002 | CN1351598A Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/29/2002 | CN1351092A Midezole-phosphate as accelerator for dicyandiamide in epoxy composition in a separated container |
| 05/29/2002 | CN1351091A 2-phenylmidezole-phosphate as accelerator for acid anhydride curing agent in epoxy composition in a separated container |
| 05/28/2002 | US6395731 Anticoagulants |
| 05/28/2002 | US6395724 Multibinding inhibitors of cyclooxygenase-2 |
| 05/28/2002 | US6395367 Electroconductivity |
| 05/23/2002 | WO2002040507A2 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers |
| 05/23/2002 | WO2002040484A2 Novel imidazole derivatives, production method thereof and use thereof |
| 05/23/2002 | WO2002040470A1 Imidazole derivatives, process for their preparation and their use |
| 05/23/2002 | WO2002040454A1 Process for manufacture of imidazoles |
| 05/23/2002 | WO2002040453A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 05/23/2002 | WO2002040442A1 Method of introducing amino group and method of synthesizing amino acid |
| 05/23/2002 | WO2002040009A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 05/23/2002 | WO2002039991A2 Prevention of development of dyskinesias |
| 05/23/2002 | WO2002039970A1 Novel coupler for use in oxidative hair dyeing |
| 05/23/2002 | WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors |
| 05/23/2002 | WO2001079180A3 5-substituted tetralones as inhibitors of ras farnesyl transferase |
| 05/23/2002 | WO2001079179A3 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase |
| 05/23/2002 | WO2001070703A3 Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | US20020061989 Method of controlling polymer molecular weight and structure |
| 05/23/2002 | US20020061919 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1h-imidazol-1-yl)methyl}-4h-carbazol-4-one |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | US20020061879 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | DE10056547A1 Karl-Fischer-Reagenz Karl Fischer reagent |
| 05/23/2002 | CA2429437A1 Imidazole derivatives, process for their preparation and their use |
| 05/23/2002 | CA2428857A1 Process for manufacture of imidazoles |
| 05/23/2002 | CA2427900A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 05/22/2002 | EP1207389A1 Karl-Fischer-Reagent |
| 05/22/2002 | EP1207160A1 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
| 05/22/2002 | EP1206937A1 Nitroimidazole external preparations for dermatosis |
| 05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |
| 05/22/2002 | EP1206455A1 ALPHAvBETA3 INTEGRIN INHIBITORS |
| 05/22/2002 | EP1206454A1 NOVEL INTEGRIN ALPHAvBETA3 INHIBITORS |
| 05/22/2002 | EP1206446A1 Carboxylic acid amides, their production and their use as drugs |
| 05/22/2002 | EP0766676B1 Compounds for inhibiting phosphodiesterase iv |
| 05/22/2002 | EP0563238B1 Imidazolyl-alkenoic acids |
| 05/22/2002 | CN1350531A Azole compounds and herbicide compositions |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/22/2002 | CN1085208C Process for preparing eprosartan |
| 05/21/2002 | US6392057 Method for the production of n,n′-carbonyldiazoles |
| 05/21/2002 | US6391913 Derivatives of paclitaxel, method for producing same and uses thereof |
| 05/21/2002 | US6391904 Bone disorders |
| 05/16/2002 | WO2002038105A2 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002026697A3 Aromatic derivatives with hiv integrase inhibitory properties |
| 05/16/2002 | WO2001083465A3 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/16/2002 | US20020058784 Generation of preferential compound; obtain sample of diamino acid such as 2,3 diaminopropionic acid, incubate with compound with free amino group, recover urein |
| 05/16/2002 | US20020058772 Method of controlling polymer molecular weight and structure |
| 05/16/2002 | US20020058768 For use in addition polymerization of olefins |
| 05/16/2002 | US20020058665 For use in cancer therapy |
| 05/16/2002 | US20020058195 High contrast, containing novel type of nucleating agent |
| 05/16/2002 | US20020056827 Piezoelectric element and process for production thereof |
| 05/16/2002 | US20020056633 Preparation and use of ionic liquids in microwave-assisted chemical transformations |
| 05/16/2002 | DE10053795A1 5-HT6 Receptor antagonist medicaments, useful for treating central nervous system disorders such as Alzheimer's disease, comprising naphthalene N-phenylsulfonamide derivatives |
| 05/16/2002 | DE10042786A1 N-Heteroarylmethyl-p-phenylendiamin-Derivate sowie diese Verbindungen enthaltende Oxidationshaarfärbemittel N-Heteroarylmethyl-p-phenylenediamine derivatives containing these compounds as well as oxidation hair |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204644A1 Synthesis of substituted amidines |
| 05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
| 05/15/2002 | EP0778833B1 Endothelin receptor antagonists |
| 05/15/2002 | EP0748314B1 Tetrasubstituted imidazole derivatives, method for preparing the same, use thereof as drugs, and pharmaceutical compositions containing the same |
| 05/15/2002 | EP0733621B1 Novel imidazole derivative and process for producing the same |
| 05/15/2002 | EP0729460B1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/15/2002 | CN1349532A Substituted benzoylisoxazoles and the use thereof as herbicides |
| 05/15/2002 | CN1349530A 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 05/15/2002 | CN1349519A Glucokinase activators |
| 05/15/2002 | CN1349506A Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1084746C 1,2,3-benzothiadiazole derivatives |
| 05/15/2002 | CN1084742C Process for preparing 3-phenyl-1-methylenedioxyphenyl-indame-2-carboxylic acid derivatives |
| 05/15/2002 | CN1084618C Use of serotonin antagonists (5HT3) for treatment disease |
| 05/14/2002 | US6388091 In presence of a halosilane compound; crystallization, purification |
| 05/14/2002 | US6388090 Imidazole derivatives |
| 05/14/2002 | US6388071 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/14/2002 | US6388004 Aqueous solution of ammonium sulfide containing sodium thiocyanate |
| 05/14/2002 | US6387926 Inhibitors of farnesyl protein transferase |
| 05/14/2002 | US6387906 Dermatophytes |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |